Journal of Spectroscopy

Journal of Spectroscopy / 2004 / Article

Open Access

Volume 18 |Article ID 186521 | 7 pages | https://doi.org/10.1155/2004/186521

Biodistribution and biocompatibility investigation in magnetoliposome treated mice

Abstract

Magnetoliposomes (ML's) may be successfully applied for several purposes. A dimyristoylphosphatidyl‒choline‒based ML (ML‒2) sample was developed as a precursor of more complex thermal cancer therapy systems. The present study reports on morphology and magnetic resonance (MR) investigations carried out with the magnetite‒based ML‒2 sample. For the experiments, adult female Swiss mice were endovenously treated with a bolus dose of 100 µl of ML‒2. Morphology and room‒temperature MR studies (X‒band experiments) were performed in several organs collected from 1 hour to 28 days after ML administration. Histological data showed magnetic nanoparticle (MNP) clusters up to the 28th day in the liver and spleen tissues. In spite of the presence of MNP clusters, no morphological alterations were observed, supporting the biocompatibility of the ML‒2. MR signal was detected only in the liver and spleen tissues and showed that the MNP's concentration was not altered from 48 hours to 28 days after ML injection. Using MR data, important pharmacokinetic parameters, such as the effective clearance (half‒life) and peak concentration, were obtained for the liver and spleen.

Copyright © 2004 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

64 Views | 432 Downloads | 16 Citations
 PDF  Download Citation  Citation
 Order printed copiesOrder

Related articles

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.